TP53 and non-small cell lung carcinoma: Additionally, our research proposed the following consideration: whether specifically activated p53 expression in NSCLC tumor via gene engineering tools could ameliorate mortality and morbidity of NSCLC, or other cancers, providing more beneficial effects to improve the outcomes.